145 related articles for article (PubMed ID: 38192663)
1. Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma.
Shih HJ; Kuo MC; Lin TL; Kao HW; Wu JH; Hung YS; Ou CW; Su YJ; Chang H
Oncol Lett; 2024 Feb; 27(2):57. PubMed ID: 38192663
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP.
Halahleh K; Yaseen A; Muradi I; Al-Ibraheem A; Sultan I; Ma'koseh M
J Blood Med; 2023; 14():147-157. PubMed ID: 36846350
[TBL] [Abstract][Full Text] [Related]
3. Primary mediastinal large B-cell lymphoma (PMLBCL) in Chinese patients: clinical characteristics and prognostic factors.
Zhu YJ; Huang JJ; Xia Y; Zhao W; Jiang WQ; Lin TY; Huang HQ; Li ZM
Int J Hematol; 2011 Aug; 94(2):178-184. PubMed ID: 21800075
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 82 cases of primary mediastinal large B cell lymphoma].
Wang J; Hu C; Zhao Y; Yi P; Huang M; Zhang G
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):491-4. PubMed ID: 24985169
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
[TBL] [Abstract][Full Text] [Related]
6. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
7. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
8. Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Vassilakopoulos TP; Michail M; Papageorgiou S; Kourti G; Angelopoulou MK; Panitsas F; Sachanas S; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Hatzimichael E; Kotsopoulou M; Dimou M; Variamis E; Boutsis D; Terpos E; Dimopoulou MN; Karakatsanis S; Michalis E; Karianakis G; Tsirkinidis P; Vadikolia C; Poziopoulos C; Pigaditou A; Vrakidou E; Economopoulos T; Kyriazopoulou L; Siakantaris MP; Kyrtsonis MC; Symeonidis A; Anargyrou K; Papaioannou M; Hatjiharissi E; Vervessou E; Tsirogianni M; Palassopoulou M; Gainaru G; Stefanoudaki E; Zikos P; Tsirigotis P; Tsourouflis G; Assimakopoulou T; Konstantinidou P; A Papadaki H; Megalakaki K; Dimopoulos MA; Pappa V; Karmiris T; Roussou P; Panayiotidis P; Konstantopoulos K; Pangalis GA
Oncologist; 2021 Jul; 26(7):597-609. PubMed ID: 33870594
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
Rapiti N; Abdelatif N; Moosa MS
PLoS One; 2022; 17(9):e0272282. PubMed ID: 36048870
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
11. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of surgery and rituximab in primary gastric diffuse large B-cell lymphoma].
Huang HW; Jiang YB; Fu TW; Xu T; Chen XC; Jin ZM; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):602-6. PubMed ID: 27535862
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of NCCN-International Prognostic Index (NCCN-IPI) for patients with peripheral T-cell lymphoma treated with CHOP-based chemotherapy].
Zhang MC; Xu PP; Zhong HJ; Zhao X; Zhao WL; Cheng S
Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):772-777. PubMed ID: 29081194
[No Abstract] [Full Text] [Related]
14. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
15. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
Yang Y; Wang L; Ma Y; Han T; Huang M
Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
17. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.
Holzhäuser E; Berlin M; Wollschläger D; Bezold T; Mayer A; Heß G; Schmidberger H
Strahlenther Onkol; 2017 Dec; 193(12):1014-1023. PubMed ID: 28748453
[TBL] [Abstract][Full Text] [Related]
19. Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.
Lisenko K; Dingeldein G; Cremer M; Kriegsmann M; Ho AD; Rieger M; Witzens-Harig M
BMC Cancer; 2017 May; 17(1):359. PubMed ID: 28532396
[TBL] [Abstract][Full Text] [Related]
20. Role of radiotherapy in the treatment of primary mediastinal large B-cell lymphoma.
Wang J; Liu X; Ma F; Huang M; Kallychurn YS; Hu C
Oncol Lett; 2015 Nov; 10(5):2925-2930. PubMed ID: 26722265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]